Iannounced a review of the pricing criteria, including manufacturing margins and profits for distributors and pharmacists, according to the decree of December 13, 2013.
According to Al3omkAmine Tahraoui insisted on the need to continue to improve the accessibility of medicines through robust pharmaceutical policies and increased support for national production. He said Morocco carries out price comparisons with around 20 countries, including France and Spain, to guarantee competitive prices.
The ministry is taking steps to further reduce prices, particularly focusing on generic drugs. A recent law includes a significant tax deduction for 4,500 medications, which has already helped reduce costs. In addition, a decision is in preparation to reduce the prices of 169 essential medicines, including those used to treat chronic diseases.
Tahraoui also addressed the recurring problems of drug shortages, often caused by production interruptions abroad. He highlighted the importance of increasing local production to overcome these challenges. The ministry allocates 1.8 billion dirhams for the purchase of medicines in the current budget, and works in collaboration with the Ministry of Economy and Finance to ensure the necessary financing.
To improve drug stock management, the ministry is developing a centralized IT system to efficiently monitor and distribute drugs across the country, strengthening the capacity to respond quickly to shortage areas.
